Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China flag China · Delayed Price · Currency is CNY
31.50
+0.23 (0.74%)
Apr 29, 2026, 11:54 AM CST

SHE:003017 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
452.76441.28353.99382.37131.11131.88
Trading Asset Securities
8.818.7640.45-296.48279.77
Cash & Short-Term Investments
461.56460.04394.44382.37427.59411.65
Cash Growth
23.69%16.63%3.16%-10.58%3.87%-6.33%
Accounts Receivable
182.12163.66127.05103.94138.96134.24
Other Receivables
1.711.455.776.599.4518.65
Receivables
183.83165.11132.82110.54148.41152.89
Inventory
112.38107.66119.78152.23126.87161.61
Prepaid Expenses
--0.310.320.350.25
Other Current Assets
40.0738.5143.216.1824.9416.3
Total Current Assets
797.84771.31690.55661.63728.16742.7
Property, Plant & Equipment
830.14800.78681.46671.49616.17528.02
Long-Term Investments
101.19100.85121.3954.842.52.52
Other Intangible Assets
96.0886.1791.0693.3595.3656.73
Long-Term Deferred Tax Assets
22.7227.3532.3144.1745.465.54
Long-Term Deferred Charges
1.821.892.1-0.050.1
Other Long-Term Assets
29.1430.134.6721.1820.3638.73
Total Assets
1,8791,8181,6541,5471,5081,374
Accounts Payable
223.51225.39158.91189.42125.77149.16
Accrued Expenses
12.6821.8522.3821.5828.7511.35
Short-Term Debt
377.83345.25358.06180.43252.11139.07
Current Portion of Long-Term Debt
--9.51-30.03-
Current Portion of Leases
---0.87--
Current Income Taxes Payable
7.6317.0600.07-0.15
Current Unearned Revenue
9.735.063.695.788.037.91
Other Current Liabilities
19.8517.9715.1632.133.549.53
Total Current Liabilities
651.23632.58567.7430.26478.24317.16
Long-Term Debt
27.5220.01-69.06-39.8
Long-Term Leases
1.641.64---0.87
Long-Term Unearned Revenue
7.187.519.0111.3511.969.6
Long-Term Deferred Tax Liabilities
19.1719.9823.6927.7932.8116.21
Total Liabilities
706.73681.72600.4538.47523.01383.64
Common Stock
848484846060
Additional Paid-In Capital
548.94545.79528.23519.47537.19563.99
Retained Earnings
536.39504.96455.2428.13413.12366.71
Treasury Stock
-6.13-6.13-17.93-25.42-25.42-
Comprehensive Income & Other
3.863.032.662.020.160.01
Total Common Equity
1,1671,1321,0521,008985.05990.71
Minority Interest
5.135.10.99---
Shareholders' Equity
1,1721,1371,0531,008985.05990.71
Total Liabilities & Equity
1,8791,8181,6541,5471,5081,374
Total Debt
406.99366.9367.56250.37282.14179.74
Net Cash (Debt)
54.5893.1426.87132145.45231.91
Net Cash Growth
10.15%246.57%-79.64%-9.25%-37.28%-40.47%
Net Cash Per Share
0.661.130.331.631.782.76
Filing Date Shares Outstanding
81.248283.0181.7580.0884
Total Common Shares Outstanding
81.248283.2381.280.0884
Working Capital
146.61138.74122.85231.38249.92425.53
Book Value Per Share
14.3713.8012.6412.4212.3011.79
Tangible Book Value
1,0711,045961.1914.85889.69933.98
Tangible Book Value Per Share
13.1812.7511.5511.2711.1111.12
Buildings
--338.1271.87270.86218.74
Machinery
--574.75544.06569.59451.65
Construction In Progress
--155.15180.8452.1584.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.